First Eagle Investment Management LLC lifted its stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU – Free Report) by 10.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 666,048 shares of the company’s stock after acquiring an additional 60,813 shares during the period. First Eagle Investment Management LLC’s holdings in InfuSystem were worth $4,549,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Rhumbline Advisers grew its position in InfuSystem by 13.8% in the second quarter. Rhumbline Advisers now owns 17,658 shares of the company’s stock valued at $121,000 after acquiring an additional 2,145 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in InfuSystem by 52.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock valued at $178,000 after purchasing an additional 8,917 shares in the last quarter. Panagora Asset Management Inc. purchased a new stake in InfuSystem during the 2nd quarter worth $208,000. ARS Investment Partners LLC lifted its holdings in InfuSystem by 11.4% in the 2nd quarter. ARS Investment Partners LLC now owns 33,510 shares of the company’s stock worth $229,000 after buying an additional 3,422 shares in the last quarter. Finally, Perritt Capital Management Inc boosted its position in InfuSystem by 169.4% in the 2nd quarter. Perritt Capital Management Inc now owns 38,500 shares of the company’s stock valued at $263,000 after buying an additional 24,207 shares during the last quarter. 71.13% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised InfuSystem from a “buy” rating to a “strong-buy” rating in a research report on Friday.
InfuSystem Stock Performance
INFU stock opened at $6.50 on Friday. The company has a market cap of $138.42 million, a price-to-earnings ratio of -650,000.00 and a beta of 1.46. The company has a current ratio of 2.07, a quick ratio of 1.64 and a debt-to-equity ratio of 0.64. InfuSystem Holdings, Inc. has a 52-week low of $5.74 and a 52-week high of $10.99.
InfuSystem (NYSE:INFU – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $33.70 million during the quarter. InfuSystem had a net margin of 0.28% and a return on equity of 0.70%.
About InfuSystem
InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Recommended Stories
- Five stocks we like better than InfuSystem
- How to Start Investing in Real Estate
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 5 Top Rated Dividend Stocks to Consider
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFU – Free Report).
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
